163 related articles for article (PubMed ID: 36809933)
1. Targeting Ion Channels for the Treatment of Glioma.
Keluth S; Jitte S; Bhushan R; Ranjan OP; Murti K; Ravichandiran V; Kumar N
Mini Rev Med Chem; 2023; 23(12):1298-1318. PubMed ID: 36809933
[TBL] [Abstract][Full Text] [Related]
2. Ion Channels in Gliomas-From Molecular Basis to Treatment.
Elias AF; Lin BC; Piggott BJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768856
[TBL] [Abstract][Full Text] [Related]
3. Ion Channels and Their Role in the Pathophysiology of Gliomas.
Takayasu T; Kurisu K; Esquenazi Y; Ballester LY
Mol Cancer Ther; 2020 Oct; 19(10):1959-1969. PubMed ID: 33008831
[TBL] [Abstract][Full Text] [Related]
4. Roles of TRPM channels in glioma.
Chen Z; Xie H; Liu J; Zhao J; Huang R; Xiang Y; Wu H; Tian D; Bian E; Xiong Z
Cancer Biol Ther; 2024 Dec; 25(1):2338955. PubMed ID: 38680092
[TBL] [Abstract][Full Text] [Related]
5. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
6. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL
Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063
[TBL] [Abstract][Full Text] [Related]
7. Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives.
Lefranc F
Front Cell Dev Biol; 2021; 9():618961. PubMed ID: 34458247
[TBL] [Abstract][Full Text] [Related]
8. Potential biochemical therapy of glioma cancer.
Yin LT; Fu YJ; Xu QL; Yang J; Liu ZL; Liang AH; Fan XJ; Xu CG
Biochem Biophys Res Commun; 2007 Oct; 362(2):225-9. PubMed ID: 17707767
[TBL] [Abstract][Full Text] [Related]
9. Potassium Ion Channels in Glioma: From Basic Knowledge into Therapeutic Applications.
Younes S; Mourad N; Salla M; Rahal M; Hammoudi Halat D
Membranes (Basel); 2023 Apr; 13(4):. PubMed ID: 37103862
[TBL] [Abstract][Full Text] [Related]
10. Novel Ion Channel Targets and Drug Delivery Tools for Controlling Glioblastoma Cell Invasiveness.
Varricchio A; Ramesh SA; Yool AJ
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769339
[TBL] [Abstract][Full Text] [Related]
11. Communication of Glioma cells with neuronal plasticity: What is the underlying mechanism?
Melgarejo da Rosa M
Neurochem Int; 2020 Dec; 141():104879. PubMed ID: 33068685
[TBL] [Abstract][Full Text] [Related]
12. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
13. The role of ion channels in malignant brain tumors.
Simon OJ; Müntefering T; Grauer OM; Meuth SG
J Neurooncol; 2015 Nov; 125(2):225-35. PubMed ID: 26334315
[TBL] [Abstract][Full Text] [Related]
14. Membrane-Depolarizing Channel Blockers Induce Selective Glioma Cell Death by Impairing Nutrient Transport and Unfolded Protein/Amino Acid Responses.
Niklasson M; Maddalo G; Sramkova Z; Mutlu E; Wee S; Sekyrova P; Schmidt L; Fritz N; Dehnisch I; Kyriatzis G; Krafcikova M; Carson BB; Feenstra JM; Marinescu VD; Segerman A; Haraldsson M; Gustavsson AL; Hammarström LG; Jenmalm Jensen A; Uhrbom L; Altelaar AF; Linnarsson S; Uhlén P; Trantirek L; Vincent CT; Nelander S; Enger PØ; Andäng M
Cancer Res; 2017 Apr; 77(7):1741-1752. PubMed ID: 28087597
[TBL] [Abstract][Full Text] [Related]
15. Ion channels and amino acid transporters support the growth and invasion of primary brain tumors.
Sontheimer H
Mol Neurobiol; 2004 Feb; 29(1):61-71. PubMed ID: 15034223
[TBL] [Abstract][Full Text] [Related]
16. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro.
Wang WX; Ji YH
J Neurooncol; 2005 May; 73(1):1-7. PubMed ID: 15933810
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ
J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501
[TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas.
Bomben VC; Turner KL; Barclay TT; Sontheimer H
J Cell Physiol; 2011 Jul; 226(7):1879-88. PubMed ID: 21506118
[TBL] [Abstract][Full Text] [Related]
19. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas.
Bomben VC; Sontheimer HW
Cell Prolif; 2008 Feb; 41(1):98-121. PubMed ID: 18211288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]